Reply to the letter to the editor 'Is the pursuit of a higher impact factor fully justified?'
Drug Development Department (DITEP), Gustave Roussy Cancer Centre, Université Paris-Saclay, 114 Rue Eduard Vaillant,  Villejuif, France.
J-C
JC
Soria